Friday, March 06, 2020 9:48:14 PM
Hi Whiskey..
Its been a long time since you and Bourbon turned me on to this stock during penny stages. I always wondered why you haven't post so long. Now I learned from your recent post why, nevertheless your posting record is not much but I can imagine, IT'S POTENT. I here you LOUD and CLEAR on what you post! Especially, about AVXL being a good company with the goods despite of our sink or swim market at present.
The life boat as you mentioned, I will be watching along with the band. I must say this drug in contrast with regular market day-to-day products essential in our societies, both, domestically and abroad ,will continue to decent and flourish , as our markets will revert back to business as usual. A cure for this virus is imminent and it will solve world wide problems. Evolution and human existence will prevail.
The unfortunate aspect of it all is that humans whom have died from it, and the families that suffers as a result, (like we need anymore sufferings). At present this evil element exist and continue its wrath. I really wonder where it really came from and whom is behind it? Thats a scary feeling and thought to have these days.
As far as the near future goes...humanity will find a way and we are still left with AVXL eradicating what has killed millions thus far (needless to mention family members in my world and other board members) and millions of others. Who knows what AVXL can contribute to this crisis today!?
I say this, old investor, thanks for the start w/ Bourbon. I will with all do respect ,board stranger, wear a life vest and will be by the lifeboats. LOL! Women and children first of course,LOL! Science is the KEY!
Stay well stranger and thanks for the HOT TIP!
My Best.
N.Y.C.!
Homestreet.
P.S.
DR.SPOCK USED TO SAY LIVE LONG AND PROPER!
Its been a long time since you and Bourbon turned me on to this stock during penny stages. I always wondered why you haven't post so long. Now I learned from your recent post why, nevertheless your posting record is not much but I can imagine, IT'S POTENT. I here you LOUD and CLEAR on what you post! Especially, about AVXL being a good company with the goods despite of our sink or swim market at present.
The life boat as you mentioned, I will be watching along with the band. I must say this drug in contrast with regular market day-to-day products essential in our societies, both, domestically and abroad ,will continue to decent and flourish , as our markets will revert back to business as usual. A cure for this virus is imminent and it will solve world wide problems. Evolution and human existence will prevail.
The unfortunate aspect of it all is that humans whom have died from it, and the families that suffers as a result, (like we need anymore sufferings). At present this evil element exist and continue its wrath. I really wonder where it really came from and whom is behind it? Thats a scary feeling and thought to have these days.
As far as the near future goes...humanity will find a way and we are still left with AVXL eradicating what has killed millions thus far (needless to mention family members in my world and other board members) and millions of others. Who knows what AVXL can contribute to this crisis today!?
I say this, old investor, thanks for the start w/ Bourbon. I will with all do respect ,board stranger, wear a life vest and will be by the lifeboats. LOL! Women and children first of course,LOL! Science is the KEY!
Stay well stranger and thanks for the HOT TIP!
My Best.
N.Y.C.!
Homestreet.
P.S.
DR.SPOCK USED TO SAY LIVE LONG AND PROPER!
Recent AVXL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
